Acupuncture for Sleep Fragmentation in Older Adults: A Single-Arm Pilot Study
Translational Research on Acupuncture Modulation of Sleep Fragmentation and Glymphatic Function in Aging: A Single-Arm Pilot Study
This single-group pilot study will enroll 20 adults aged 60 years or older with persistent poor sleep. All participants will receive a standardized 6-week acupuncture program. The study will assess feasibility and preliminary changes in actigraphy-derived sleep fragmentation, self-reported sleep, brain DTI-ALPS imaging, internal jugular venous ultrasonography, and CERAD-NB word-list memory performance.
研究概览
详细说明
After written informed consent, participants will complete cognitive and mood screening. Baseline assessments include PSQI, ISI, ESS, CERAD-NB word-list memory testing, one night of home polysomnography, 7 days of actigraphy, brain MRI for the DTI-ALPS index, and internal jugular venous ultrasonography. Participants will then receive acupuncture twice weekly for 6 weeks, for 12 sessions, with each session lasting approximately 20 to 30 minutes. ISI will also be assessed at Weeks 2 and 4. At Week 6, baseline assessments will be repeated except for home polysomnography. PSQI, ISI, and ESS will be collected again approximately 3 months after treatment as an optional follow-up. Missing data from this optional follow-up alone will not exclude a participant from the per-protocol population. Exploratory analyses will examine whether actigraphy-derived physical activity and light exposure are associated with, or modify, changes in the registered sleep, imaging, and cognitive outcomes.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Taoyuan
-
Taoyuan、Taoyuan、台湾、333
- Linkou Chang Gung Memorial Hospital
-
接触:
- Geng-Hao Liu
- 电话号码:+886-975362734
- 邮箱:ghliu.wis@gmail.com
-
Taoyuan、Taoyuan、台湾、333
- Taoyuan Chang Gung Memorial Hospital
-
接触:
- Geng-Hao Liu
- 电话号码:+886-975362734
- 邮箱:ghliu.wis@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age 60 years or older.
- Subjective poor sleep for at least 3 months.
- Pittsburgh Sleep Quality Index (PSQI) total score greater than 5.
- Willing and able to complete study assessments and the 6-week intervention.
- Mini-Mental State Examination (MMSE) score of 24 or higher.
- Provides written informed consent.
Exclusion Criteria:
- Diagnosed dementia, Parkinson disease, or another progressive neurodegenerative disorder.
- Stroke or severe head injury within the prior year.
- Unstable major psychiatric illness.
- AD8 score of 2 or higher or Geriatric Depression Scale (GDS) score of 5 or higher.
- Severe sensory or comprehension problems that prevent study participation.
- Night-shift work or frequent recent transmeridian travel.
- Current CPAP or BiPAP use, or severe obstructive sleep apnea requiring immediate treatment, such as an apnea-hypopnea index greater than 30 with oxygen desaturation.
- Use of 3 or more hypnotic medications with inability to maintain a stable dose.
- Contraindication to magnetic resonance imaging.
- Major neck surgery, neck radiation, or vascular anomaly that interferes with jugular ultrasonography.
- Severe unstable systemic disease.
- Severe coagulopathy or anticoagulation that makes acupuncture unsuitable.
- Infection or wound at an acupuncture site.
- Severe gait instability or inability to attend scheduled visits.
- Any other condition that the investigator considers unsuitable for participation.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Acupuncture
Participants receive a 6-week standardized acupuncture program. |
Participants will receive acupuncture at Baihui (GV20), Anmian (EX-HN22), Zusanli (ST36), and Taixi (KI3) twice weekly for 6 weeks, for a total of 12 sessions. Needles will be retained for approximately 20 to 30 minutes per session. No comparator arm is used in this pilot. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in 7-day mean wake after sleep onset from baseline to Week 6
大体时间:Baseline and Week 6
|
Change equals the Week 6 mean minus the baseline mean. Wake after sleep onset (WASO) is the total minutes scored awake between sleep onset and final awakening for each valid night. Sleep is measured with Actiwatch 2 (Philips Respironics) worn on the nondominant wrist, recorded in 60-second epochs, and scored with Philips Actiware version 6.0.9 using sleep diaries. Each timepoint is the mean across all valid nights in the 7-day assessment window. A timepoint is valid if it includes at least 5 valid nights, including at least 1 weekend night; otherwise it is treated as missing. Unit: minutes. |
Baseline and Week 6
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in 7-day mean sleep efficiency from baseline to Week 6
大体时间:Baseline and Week 6
|
Change equals the Week 6 mean minus the baseline mean. Sleep efficiency is the percentage of time in bed scored as sleep for each valid night. Sleep is measured with Actiwatch 2 (Philips Respironics) worn on the nondominant wrist, recorded in 60-second epochs, and scored with Philips Actiware version 6.0.9 using sleep diaries. Each timepoint is the mean across all valid nights in the 7-day assessment window. A timepoint is valid if it includes at least 5 valid nights, including at least 1 weekend night; otherwise it is treated as missing. Unit: percentage points. |
Baseline and Week 6
|
|
Change in Pittsburgh Sleep Quality Index total score over time
大体时间:Baseline, Week 6, and approximately 3 months after treatment
|
The Pittsburgh Sleep Quality Index total score ranges from 0 to 21; higher scores indicate poorer sleep quality. Change at Week 6 and at the optional approximately 3-month post-treatment follow-up equals the respective follow-up score minus baseline. |
Baseline, Week 6, and approximately 3 months after treatment
|
|
Change in 7-day mean number of awakenings from baseline to Week 6
大体时间:Baseline and Week 6
|
Change equals the Week 6 mean minus the baseline mean. Actiware-derived awakenings are counted for each valid night. Sleep is measured with Actiwatch 2 (Philips Respironics) worn on the nondominant wrist, recorded in 60-second epochs, and scored with Philips Actiware version 6.0.9 using sleep diaries. Each timepoint is the mean across all valid nights in the 7-day assessment window. A timepoint is valid if it includes at least 5 valid nights, including at least 1 weekend night; otherwise it is treated as missing. Unit: awakenings per night. |
Baseline and Week 6
|
|
Change in 7-day mean sleep fragmentation index from baseline to Week 6
大体时间:Baseline and Week 6
|
Change equals the Week 6 mean minus the baseline mean. For each valid night, the Actiware 6.0.9 sleep fragmentation index is the sum of (1) the percentage of epochs classified as mobile during the sleep interval and (2) the percentage of all immobile bouts lasting no more than 1 minute. Higher values indicate greater sleep fragmentation. Actiwatch 2 is worn on the nondominant wrist and recorded in 60-second epochs. Each timepoint is the mean across valid nights in the 7-day window. A timepoint requires at least 5 valid nights, including at least 1 weekend night; otherwise it is missing. Unit: percentage points. |
Baseline and Week 6
|
|
Change in Insomnia Severity Index total score over time
大体时间:Baseline, Weeks 2, 4, and 6, and approximately 3 months after treatment
|
The Insomnia Severity Index total score ranges from 0 to 28; higher scores indicate greater insomnia severity. Change at Weeks 2, 4, and 6 and at the optional approximately 3-month post-treatment follow-up equals the respective follow-up score minus baseline. |
Baseline, Weeks 2, 4, and 6, and approximately 3 months after treatment
|
|
Change in Epworth Sleepiness Scale total score over time
大体时间:Baseline, Week 6, and approximately 3 months after treatment
|
The Epworth Sleepiness Scale total score ranges from 0 to 24; higher scores indicate greater daytime sleepiness. Change at Week 6 and at the optional approximately 3-month post-treatment follow-up equals the respective follow-up score minus baseline. |
Baseline, Week 6, and approximately 3 months after treatment
|
|
Change in diffusion tensor imaging along the perivascular space index from baseline to Week 6
大体时间:Baseline and Week 6
|
Change equals the Week 6 value minus the baseline value for the diffusion tensor imaging along the perivascular space (DTI-ALPS) index. Unit: unitless (dimensionless index). |
Baseline and Week 6
|
|
Change in side-specific internal jugular vein time-averaged mean blood-flow velocity from baseline to Week 6
大体时间:Baseline and Week 6
|
Change equals the Week 6 value minus baseline for time-averaged mean velocity measured by pulsed-wave Doppler ultrasonography with the participant supine and the head in a neutral position. The left and right internal jugular veins are measured and analyzed separately; values are not combined by a simple bilateral average. Repeated measurements for each side are averaged. Unit: centimeters per second (cm/s). |
Baseline and Week 6
|
|
Change in side-specific internal jugular vein cross-sectional area from baseline to Week 6
大体时间:Baseline and Week 6
|
Change equals the Week 6 value minus baseline for cross-sectional area measured by transverse B-mode ultrasonography with the participant supine and the head in a neutral position. The left and right internal jugular veins are measured and analyzed separately; values are not combined by a simple bilateral average. Repeated measurements for each side are averaged. Minimal transducer pressure is used to avoid vein compression. Unit: square centimeters (cm²). |
Baseline and Week 6
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in CERAD-NB word-list memory composite score from baseline to Week 6
大体时间:Baseline and Week 6
|
Change equals the Week 6 score minus baseline. The composite is the sum of word-list learning across 3 trials (0-30), delayed recall (0-10), and recognition discriminability (0-10), for a total range of 0-50; higher scores indicate better memory performance. Recognition discriminability is calculated as correct "Yes" responses plus correct "No" responses minus 10; values below 0 are scored as 0. Remote memory is not included in this composite. |
Baseline and Week 6
|
|
Proportion of participants completing at least 10 of 12 acupuncture sessions
大体时间:Through Week 6
|
Number of enrolled participants who complete at least 10 of the 12 planned acupuncture sessions divided by the total number enrolled, multiplied by 100. This threshold corresponds to at least 80% treatment adherence. Unit: percentage of participants. |
Through Week 6
|
|
Proportion of participants completing the Week 6 primary outcome assessment
大体时间:Week 6
|
Number of enrolled participants who complete the Week 6 assessment of the primary outcome, 7-day mean wake after sleep onset, divided by the total number enrolled, multiplied by 100. Unit: percentage of participants. |
Week 6
|
|
Proportion of participants with valid actigraphy data at both baseline and Week 6
大体时间:Baseline and Week 6
|
Number of enrolled participants with valid actigraphy timepoints at both baseline and Week 6 divided by the total number enrolled, multiplied by 100. Each timepoint requires at least 5 valid nights, including at least 1 weekend night. Unit: percentage of participants. |
Baseline and Week 6
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 202502000A3-PILOT
- NSTC 115-2320-B-182-022-MY3 (其他赠款/资助编号:National Science and Technology Council, Taiwan)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.